▲
STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #2427 by analyst upside · 2026-09-28
UNH
UnitedHealth Group Incorporated
Healthcare · Market Cap $338B · P/E 24.2x
ANALYST PRICE TARGET
+27.9%
implied upside to consensus target
Current Price $376.59
Consensus Target $481.72
Bull Target $529.0
Bear Target $380.0
Analysts Covering 25
ANALYST CONSENSUS - BUY
Strong Buy
7
Buy
14
Hold
4
Sell
0
52-Week Low $255.97
52-Week High $461.62
YTD Return +14.2%
FUNDAMENTALS
Market Cap $338B
P/E Ratio (TTM) 24.2x
Forward P/E 16.7x
EPS (TTM) $15.55
PEG Ratio 1.02
Dividend Yield 2.46%
Revenue (TTM) $450.5B
Profit Margin 3.1%
52-WEEK RANGE
52-Week Low $255.97
52-Week High $461.62
Current Price $376.59
Bear Target $380.0
Bull Target $529.0
● Now $376.59 ● Target $481.72
TRADING DATA
Avg Volume 5.0M
YTD Return +14.2%
Analyst Count 25
Consensus Buy
Upside to Target +27.9%
Last Updated 2026-09-28

ANALYST SUMMARY

UnitedHealth Group Incorporated (UNH) is currently trading at $376.59 with a Wall Street consensus price target of $481.72, implying potential upside of 27.9% over the next 12 months. 25 analysts currently cover UNH, with a consensus rating of Buy - 84% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $529.0, while the most cautious has a target of $380.0.

UNH operates in the Healthcare sector with a market capitalisation of $338B. The stock is up 14.2% year-to-date and is currently trading near the upper end of its 52-week range of $255.97 – $461.62.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

AZN +27.4%
AstraZeneca PLC
$258B · P/E 24.9x · Buy
TMO -3.2%
Thermo Fisher Scientific Inc.
$250B · P/E 36.4x · Buy
ABT +18.7%
Abbott Laboratories
$175B · P/E 32.8x · Buy
AMGN -6.1%
Amgen Inc.
$224B · P/E 25.8x · Hold
DHR +2.8%
Danaher Corporation
$158B · P/E 40.0x · Buy

RECENT ANALYST CALLS

Upgrade/downgrade history for UNH, with each firm's 90-day track record across all stocks we track. See full firm rankings →

JP Morgan - Reiterated
Overweight → Overweight 2026-07-21 43% win rate (7 calls)
Mizuho - Reiterated
Outperform → Outperform 2026-07-21 Building track record
Barclays - Reiterated
Overweight → Overweight 2026-07-20 Building track record
Morgan Stanley - Reiterated
Overweight → Overweight 2026-07-17 Building track record
Keybanc - Reiterated
Overweight → Overweight 2026-07-17 Building track record
Oppenheimer - Reiterated
Outperform → Outperform 2026-07-17 14% win rate (7 calls)
Truist Securities - Reiterated
Buy → Buy 2026-07-17 Building track record
RBC Capital - Reiterated
Outperform → Outperform 2026-07-17 Building track record
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
69
out of 100
Coverage depth
25/30
Consensus clarity
22/30
Vote unanimity
20/25
Rating stability
2/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call - not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →